- Tropical Cyclone Sagar - May 2018
- Horn of Africa Crisis: 2011-2012
- Influenza A (H1N1) Pandemic - Apr 2009
- Djibouti: Floods - Apr 2004
- Djibouti: Toxic Pollution - Mar 2002
- Djibouti: Drought - Aug 1999
- Djibouti: Drought - Jul 1996
- Djibouti: Floods - Nov 1994
- Djibouti: Floods - Apr 1989
- Djibouti: Drought - Feb 1988
Most read reports
- Points de suivi des flux de populations Djibouti - Tableau de Bord - Période 1 - 31 Août 2018
- Secretary-General Hails Meeting of Eritrea, Djibouti Presidents, Hoping it Proves New Step towards Consolidating Peace, Security Gains in Region
- Cleaning up after cyclone in Djibouti
- WFP Djibouti Country Brief, July 2018
- OCHA Flash Update #1 Tropical Cyclone Sagar impacts Djibouti | 20 May 2018
In a high-security building in Kampala, Uganda, a man leads a group of sleuths investigating a potential killer. While they may go about their work with the meticulousness of police detectives, they are actually a different type of investigator. Professor Moses Joloba, Director of Uganda's Supranational Reference Laboratory, leads his team to pursue TB – the world’s leading killer among infectious diseases. The disease killed more than 1.6 million people around the world in 2017.
Action taken to ensure new Principal Recipients are found and that full grant activities resume quickly
Grants to five countries put under closer Global Fund control
GENEVA - The Global Fund to Fight AIDS, Tuberculosis and Malaria has suspended funding of two malaria grants in Mali with immediate effect and has terminated a third grant for tuberculosis (TB) after it found evidence of misappropriation and unjustified expenditure. Management of the two suspended grants will be transferred to a new Principal Recipient.
The government of Mali has condemned the embezzlement of funds …
88 Million Bed Nets Distributed for Malaria
Geneva - The Global Fund to Fight AIDS, Tuberculosis and Malaria today announced that 2.3 million people living with HIV have been reached with lifesaving antiretroviral (ARV) treatment through AIDS programs it supports, a 31 per cent increase over results reported a year ago.
Global Fund-supported tuberculosis programs have so far put more than 5.4 million people on effective TB drugs treatment. Tuberculosis is the leading cause of death among HIV-infected people; the World Health Organization estimates that TB accounts for up to a …
This fact sheet outlines the principles and approach in determining the number of people on antiretroviral drugs (ARVs) for HIV/AIDS treatment, with a breakdown of the results by country, and answers to commonly-asked questions.
Question 1: How many people are receiving ARVs from programs supported by Global Fund grants?
As of June 1st 2009, programs supported by the Global Fund have reported 2.3 million people currently on ARVs for treatment of HIV/AIDS.
Question 2: What is the regional breakdown of people currently receiving ARVs?